We are live on ! Find out more
BCM

BML Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 129.82%
This Fund
S&P 500
This Quarter Est. Return
+77.51%
1 Year Est. Return
+129.82%
3 Year Est. Return
+394.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$29.8M
Cap. Flow
+$10.3M
Cap. Flow %
6.04%
Top 10 Hldgs %
84.84%
Holding
32
New
4
Increased
11
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
ANTX icon
AN2 Therapeutics
ANTX
+$9.98M
2
WHWK
Whitehawk Therapeutics
WHWK
+$3.23M
3
ACHL
Achilles Therapeutics
ACHL
+$2.78M
4
ADVM
Adverum Biotechnologies
ADVM
+$2.19M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$2.04M

Top Sells

Rank Stock Value
1
TECX
Tectonic Therapeutic
TECX
+$4.65M
2
LONA
LeonaBio Inc
LONA
+$2.38M
3
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$2.29M
4
DSGN icon
Design Therapeutics
DSGN
+$1.41M
5
TIL icon
Instil Bio
TIL
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 73.51%
2 Technology 1.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBRX icon
26
Forte Biosciences
FBRX
$1.57B
$394K 0.23%
70,468
– –
NXTC icon
27
NextCure
NXTC
$20.8M
$379K 0.22%
23,039
– –
VRCA icon
28
Verrica Pharmaceuticals
VRCA
$96M
$261K 0.15%
18,000
– –
HLVX
29
DELISTED
HilleVax
HLVX
$34.8K 0.02%
+19,760
New +$50.7K
LONA
30
LeonaBio Inc
LONA
$67M
– –
-90,000
Closed -$2.38M
DSGN icon
31
Design Therapeutics
DSGN
$744M
– –
-421,749
Closed -$1.41M
WING icon
32
PUT
Wingstop
WING
$3.83B
– –
-714
Closed -$3.58M
1
2

Similar funds

AIS
Accredited Investor Services St. Cloud, Minnesota $156M AUM 21.61% 1-Year Est. Return
BWM
BNB Wealth Management Silver Spring, Maryland $156M AUM
CFG
Cornerstone Financial Group Omaha, Nebraska $156M AUM 12% 1-Year Est. Return
IWA
Invera Wealth Advisors Bend, Oregon $156M AUM 22.76% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
PMSA
Patrick M. Sweeney & Associates Libertyville, Illinois $156M AUM 19.16% 1-Year Est. Return
GSWA
Good Steward Wealth Advisors Clarksville, Tennessee $156M AUM 13.06% 1-Year Est. Return
SPM
Summit Portfolio Management Las Vegas, Nevada $155M AUM

BML Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, BML Capital Management held 32 positions worth $170M, up 21% from $140M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

BML Capital Management deployed $10.3M of net new capital in Q3 2024, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was AN2 Therapeutics: 5,749,432 shares worth $6.15M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 64% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Tectonic Therapeutic, an estimated $4.65M trimmed.

  • BML Capital Management's largest Q3 2024 buy was AN2 Therapeutics: 5,749,432 shares worth $6.15M.
  • BML Capital Management added most to Achilles Therapeutics in Q3 2024, an estimated $2.78M increase.
  • BML Capital Management's biggest Q3 2024 reduction was Tectonic Therapeutic, cutting an estimated $4.65M.
  • BML Capital Management fully exited LeonaBio Inc in Q3 2024, selling an estimated $2.38M.
  • BML Capital Management's ten largest holdings make up 85% of its $170M portfolio in Q3 2024.
  • BML Capital Management opened 4 new positions and closed 3 in Q3 2024.
  • BML Capital Management's portfolio value rose 21% quarter-over-quarter to $170M.

Based on BML Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.